ClinicalTrials.Veeva

Menu

Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV) (NVCI)

H

Hopital Foch

Status

Completed

Conditions

Vomiting
Nausea

Treatments

Other: Acupuncture
Other: Auriculotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02767791
2015/34
2015-A01988-41 (Other Identifier)

Details and patient eligibility

About

The management of chemotherapy-induced nausea and vomiting (CINV) has evolved in recent years and became less frequent. CINV include early (occurring within 24 hours of chemotherapy administration) and delayed (occurring within 4 days after chemotherapy) nausea and vomiting.

Preventive treatment, such as Glucocorticoids, 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists and neurokinin 1 (NK1) receptor antagonists, are administered according to the classification in 4 grades of expected CINV

  • Very low: <10% occurrence of CINV;
  • Low: 10 to 30% occurrence of CINV;
  • Average: 30 to 90% occurrence of CINV;
  • High: > 90% occurrence of CINV. These treatments have been the subject of recommendations. Despite these available treatments, some patients still complain of vomiting, or more frequently nausea and loss of appetite.

Meanwhile, Chinese acupuncture has proven effective on the prevention of CINV as complementary treatment, mainly in the acute phase and to a lesser extent in the delayed phase. The most common points are Pericardium 6 (wrist) treated with conventional acupuncture needles, electro-acupuncture or acupressure.

Auriculotherapy (ear acupuncture) has proven effective on nausea of pregnancy and postoperative nausea, but, to our knowledge, there are no studies published on the effect of auriculotherapy on CINV.

These complementary treatments have virtually no side effects. In our institution, a simple treatment of acupuncture (2 points Pericardium 6 treated) and auriculotherapy (2 auricular point treated) is regularly use in patients who present CINV despite preventive treatment and most of them are relieved.

The investigators propose a clinical trial in this population to assess symptoms improvement in patients presenting CINV after their first administration of chemotherapy despite adapted preventive treatment. Experimental treatment with semi-permanent needles takes place during administration of the second session of chemotherapy. CINV are evaluated through the (MAT) score that measures the frequency and intensity of nausea and vomiting in the 24 hours following the session and during the 4 days after administration Chemotherapy.

Multinational Association of Supportive Care in Cancer Antiemesis Tool (MASCC), Http://www.MASCC.org/.

Enrollment

116 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • out-patient chemotherapy
  • treated nausea vomiting induced by chemotherapy (NVIC)

Exclusion criteria

  • prior treatment with acupuncture and or auriculotherapy for NVIC
  • no conventional treatment for NVIC like phytotherapy and homeopathy
  • radiotherapy (five days before and 5 days after chemotherapy)
  • MRI in the five days after first visit

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

116 participants in 4 patient groups

Acupuncture
Active Comparator group
Description:
Acupuncture wrist 6
Treatment:
Other: Acupuncture
Auriculotherapy
Active Comparator group
Description:
Auriculotherapy
Treatment:
Other: Auriculotherapy
Auriculotherapy and acupuncture
Experimental group
Description:
Auriculotherapy and acupuncture
Treatment:
Other: Acupuncture
Other: Auriculotherapy
No treatment
No Intervention group
Description:
No treatment

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems